Pharmacogenomics Issues Research Articles in April 2024 Edition
April 30, 2024
April 30, 2024
BERLIN, Germany, April 30 -- Pharmacogenomics, a peer-reviewed journal that says it features pharmacogenomics and its clinical applications, published research articles on the following topics in its April 2024 edition (Vol. 24, Issue 2):
Article:
* Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients
* Upregulation of p300 in paclitaxel-resistant TNBC: implications for . . .
Article:
* Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients
* Upregulation of p300 in paclitaxel-resistant TNBC: implications for . . .